ClinicalTrials.Veeva

Menu

Lifestyle Intervention for Rheumatoid Arthritis

B

Blue Cross Blue Shield of Vermont

Status

Terminated

Conditions

Lifestyle Risk Reduction
Rheumatoid Arthritis

Treatments

Behavioral: Intensive Lifestyle intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05554705
22-08-629-1275

Details and patient eligibility

About

The main purpose of this study is to assess whether adding a multifaceted lifestyle intervention to the standard best practice of care can be more effective than standard best practices alone for treating Rheumatoid Arthritis.

Full description

The main purpose of this study is to assess whether adding a multifaceted lifestyle intervention to the standard best practice of care can be more effective than standard best practices alone for treating Rheumatoid Arthritis. If a lifestyle intervention is effective, we expect to see improvement in functional status and decreased health care costs to the study participant and the insurer.

Enrollment

114 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. BCBSVT members who also carry the prescription benefit with BCBSVT (due to the need for tracking prescription costs).
  2. BCBSVT membership for minimum of 12 months prior to start of study (due to the need for tracking prescription costs before and after intervention).
  3. Age 18 or older
  4. Medical diagnosis of RA

Exclusion criteria

  1. Pregnancy
  2. Currently taking warfarin (since fluctuating amounts of green leafy vegetable intake can adversely affect INR levels and because we will be asking participants to increase the amount of green leafy vegetables they consume)
  3. Malignancy currently undergoing treatment (with further planned treatment at the time of enrollment) since patients undergoing cancer treatment often need to stop RA medications in order to improve immune function, and thus could be a confounder.
  4. Food allergy (including reactions such as hives, wheezing, difficulty breathing, fainting, or anaphylaxis)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

114 participants in 2 patient groups

experimental
Experimental group
Description:
standard of care + lifestyle intervention
Treatment:
Behavioral: Intensive Lifestyle intervention
control
No Intervention group
Description:
no intervention (control group)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems